Bank Of Montreal Cytokinetics Inc Transaction History
Bank Of Montreal
- $192 Billion
- Q1 2025
A detailed history of Bank Of Montreal transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of Montreal holds 15,801 shares of CYTK stock, worth $527,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,801
Previous 15,136
4.39%
Holding current value
$527,753
Previous $711,000
10.69%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$490 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$396 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$333 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$267 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$203 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.14B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...